Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
• Treatments: Miglitol

Criteria

Inclusion Criteria:

• Type2 diabetes

• Criteria of postprandial plasma glucose and HbA1c are met

Exclusion Criteria:

• Type1 diabetes

• Patients with antidiabetic drugs

• The other exclusion criteria are met